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The biofilm-associated protein Bap is a staphylococcal surface protein involved in biofilm formation. We
investigated the influence of the global regulatory locus sarA on bap expression and Bap-dependent biofilm
formation in three unrelated Staphylococcus aureus strains. The results showed that Bap-dependent biofilm
formation was diminished in the sarA mutants by an agr-independent mechanism. Complementation studies
using a sarA clone confirmed that the defect in biofilm formation was due to the sarA mutation. As expected,
the diminished capacity to form biofilms in the sarA mutants correlated with the decreased presence of Bap in
the bacterial surface. Using transcriptional fusion and Northern analysis data, we demonstrated that the sarA
gene product acts as an activator of bap expression. Finally, the bap promoter was characterized and the
transcriptional start point was mapped by the rapid amplification of cDNA ends technique. As expected, we
showed that purified SarA protein binds specifically to the bap promoter, as determined by gel shift and DNase
I footprinting assays. Based on the previous studies of others as well as our work demonstrating the role for
SarA in icaADBC and bap expression (J. Valle, A. Toledo-Arana, C. Berasain, J. M. Ghigo, B. Amorena, J. R.
Penades, and I. Lasa, Mol. Microbiol. 48:1075–1087), we propose that SarA is an essential regulator controlling
biofilm formation in S. aureus.
vivo and were less susceptible to antibiotic treatments when
forming biofilms in vitro (17).
An evaluation of the biofilm formation process of S. aureus
will likely contribute to our understanding of the infectious
process. Temporal expression of many of the virulence determinants in S. aureus has been shown to be under the control of
several genetic loci, including agr and sarA. The agr locus is a
complex multigene system that regulates virulence genes in
response to increasing cell density (for a review, see reference
30). The sarA locus codes for SarA, a 14.5-kDa DNA-binding
protein that activates agr promoters and thus can work in
concert with the agr system to control target gene transcription
(9, 11). The SarA protein can also activate some virulence
genes independently of agr (7, 44). SarA binds to a consensus
motif upstream of the ⫺35 sequences of the promoters of
SarA-dependent genes (12).
Previously, SarA was shown to be a positive regulator of S.
aureus PNAG-dependent biofilm formation (4, 41). Our results
demonstrated that nonpolar mutations of sarA in four genetically unrelated S. aureus strains decreased PNAG production
and completely impaired biofilm development, both under
steady-state and flow conditions, via an agr-independent mechanism. Real-time PCR showed that the mutation in the sarA
gene resulted in downregulation of ica operon transcription
(41). Here we analyzed the role of SarA in expression of Bap,
the other surface component involved in S. aureus biofilm
formation. As described for the icaADBC operon, the bap gene
is positively regulated by SarA by an agr-independent mechanism. Taken together, these results suggest that sarA is an important regulator of the biofilm formation process of S. aureus.

Biofilm formation is a major concern in nosocomial infections because it protects microorganisms from opsonophagocytosis and antibiotics, leading to chronic infection and sepsis
(13). To date, two surface components have been implicated in
biofilm formation by Staphylococcus aureus: (i) the product of
the icaADBC operon, which encodes proteins for the synthesis
of the polysaccharide poly-N-acetyl ␤-1-6-glucosamine
(PNAG) (14, 26), and (ii) Bap, a surface protein that is essential for biofilm formation in some bovine S. aureus strains (15).
Although the bap gene was only present in a small fraction of
bovine mastitis isolates (5%) and was absent from the 75 clinical human S. aureus isolates analyzed, all the staphylococcal
isolates harboring bap were highly adherent and strong biofilm
producers (15). The bap gene, carried in a putative composite
transposon inserted in a mobile staphylococcal pathogenicity
island (40), codes for Bap, a multidomain protein with architecture characteristic of surface-associated proteins from
gram-positive bacteria (19). Experiments carried out in vitro
have shown that Bap promotes early adherence and intercellular adhesion of S. aureus cells (15). Experimental mammary
gland infection studies have indicated that Bap might act as an
antiattachment factor that prevents initial bacterial attachment
to host tissues (16), although Bap-positive isolates were significantly more able to persist in the bovine mammary gland in
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TABLE 1. Bacterial strains used in this study
Strain or plasmid

Relevant property(ies)

S. aureus strains
V329
c104
V858
RN4220
CYL316
SH1000
Newman
PC1839
ISP546
AK1
AK2
JP60
JP61
JP62
JP63
JP64
JP65
JP66
JP67
JP68
JP69
JP70
JP71
JP72
JP73
JP74
JP75
JP76
JP77
JP78
JP79
JP80
JP81
JP82

Bovine clinical isolate, bap positive
Bovine clinical isolate, bap positive
Bovine clinical isolate, bap positive
Restriction-deficient mutant of 8325-4
Recipient strain for plasmid pCL84
Functional rsbU derivative of 8325-4
Natural isolate
8325-4 sarA::km
8325-4 agr::Tn551
8325-4 aur::ermB
8325-4 ssp::ermB
Newman with the bap gene from the V858 strain inserted in its genome
SH1000 with the bap gene from the V858 strain inserted in its genome
V329 ⌬sarA
c104 ⌬sarA
JP60 sarA::km
JP61 sarA::km
JP62 pCU1-sarA
JP63 pCU1-sarA
JP64 pCU1-sarA
JP65 pCU1-sarA
JP62 pCU1
JP63 pCU1
JP64 pCU1
JP65 pCU1
JP64 aur::ermB
JP64 ssp::ermB
JP65 aur::ermB
JP65 ssp::ermB
JP61 pJP21
JP65 pJP21
V329 ⌬agr
JP60 agr::ermB
JP61 agr::ermB

E. coli strains
DH5␣

Laboratory strain

Plasmids
pCL84
pJP17
pALC2485
pJP21
pCU1
pCU1-sarA

Integrating plasmid
pCL84 carrying the bap gene under the the control of its native promoter
Plasmid for construction of luxABCDE fusions
bap promoter-luxABCDE fusion formed by cloning the bap promoter region in plasmid pALC2485
Shuttle plasmid
pCU1 carrying sarA

MATERIALS AND METHODS
Bacterial strains and plasmids. The strains and plasmids used in this study are
listed in Table 1. Phage 85 was used to transduce plasmids and mutations
between staphylococcal strains (31).
Staphylococcal strains were cultured in trypticase soy agar (TSA) and in
trypticase soy broth (TSB) supplemented with glucose (0.25%, wt/vol) when
indicated. Media were supplemented when appropriate with chloramphenicol
(10 g/ml for plasmids pCU1 and pJP21), erythromycin (2.5 g/ml for plasmid
pMAD), or tetracycline (3 g/ml for plasmid pCL84).
DNA manipulations. Routine DNA manipulations were performed using standard procedures (3, 36). Plasmid DNA from Escherichia coli and staphylococci
was purified with a Genelute Plasmid Miniprep kit (Sigma) according to the
manufacturer’s protocol, except that the staphylococcal bacterial cells were lysed
with lysostaphin (Sigma; 12.5 g/ml) at 37°C for 1 h before plasmid purification.
Plasmids were introduced into staphylococci strains by transformation using a
previously described method (15). Restriction enzymes were purchased from
Roche and used according to the manufacturer’s instructions. Oligonucleotides
were obtained from Invitrogen.
For Southern blot hybridization, staphylococcal chromosomal DNA was extracted using a Genelute Bacterial Genomic DNA kit (Sigma) according to the
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A. L. Cheung
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2
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manufacturer’s protocol, except that the bacterial cells were lysed by lysostaphin
(Sigma; 12.5 g/ml) at 37°C for 1 h before DNA purification. DNA fragments
were transferred by alkaline capillary blotting onto nylon membranes (Hybond-N; 0.45 mm pore-size filters; Amersham Life Science) using standard
methods (3, 36). Probe labeling and DNA hybridization were performed according to the protocol supplied with the PCR-digoxigenin DNA-labeling and chemiluminescence detection kit (Roche).
Biofilm formation. Quantification of biofilm formation on abiotic surfaces was
assessed basically as described elsewhere (21). Briefly, S. aureus was grown
overnight in TSB supplemented with 0.25% glucose (TSB-glucose). The culture
was diluted 1:40 in TSB-glucose, and 200 l of this cell suspension was used per
well to inoculate sterile, 96-well polystyrene microtiter plates (Iwaki). After 18 h
of incubation at 37°C, wells were gently washed three times with 200 l of sterile
phosphate-buffered saline (PBS), air dried in an inverted position, and stained
with 0.1% safranin for 30 s. Wells were rinsed again, and the absorbance was
determined at 490 nm (Micro-ELISA Autoreader; Elx800 Bio-tek Instruments).
Each assay was performed in triplicate in five separate experiments.
Colony morphology was studied on Congo red agar as previously described
(15). A positive result indicating biofilm formation was demonstrated by the
presence of black or pink colonies with a dry crystalline surface (rough colony
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phenotype). Deficiency in biofilm formation was indicated by the presence of
smooth colonies.
Construction of S. aureus strains carrying a chromosomal copy of the bap
gene. A single-copy integrating plasmid, pCL84 (25), was used to introduce the
bap gene into S. aureus strains Newman (ATCC 25905) and SH1000. Plasmid
pCL84 carries the att site of phage L54a but lacks a replicon that functions in S.
aureus. When transformed into S. aureus CYL316, which overexpresses the L54a
integrase, the plasmid integrated into the chromosomal att site located in the geh
gene (25). As previously described, the bap gene of the S. aureus V858 strain,
including its native promoter, was amplified with Pfu DNA polymerase (Promega) by using primers Bap-1mB (5⬘-CGCGGATCCCTCTTCAGATCTACG
AATTTTCCC-3⬘) and Bap-5cE (5⬘-CGGGAATTCACTTATAGATGTGCGT
AGTC-3⬘) and was cloned in pCL84, generating pJP17 (17). Plasmid pJP17 was
transformed into CYL316 and integrated into the chromosome by homologous
recombination at the phage L54a att site. The bap gene was then transduced by
phage 85 (31) into strains Newman and SH1000, generating strains JP60 and
JP61, respectively. Correct integration of pJP17 in CYL316 and in JP60 and JP61
was verified by PCR and Southern blotting with lipase- and bap-specific probes.
Allelic exchange of chromosomal genes. The sarA, aur, ssp, and agr genes were
inactivated in S. aureus Newman and SH1000 strains by transferring the sarA,
aur, ssp, and agr mutations via phage transduction using 85 (31). A strain c104
sarA mutant was obtained basically as described elsewhere (41).
Complementation studies. To prove that the biofilm-deficient phenotype of
the mutants was due to the disruption of sarA, mutant strains were complemented with plasmids pCU1 (2) or pCU1-sarA. Plasmid pCU1-sarA carries the
sarA gene under the control of its promoter cloned in pCU1 (41). Plasmids pCU1
and pCU1-sarA were transformed into strain RN4220 by electroporation (15).
Phage 85 was used to transduce the plasmids from RN4220 to sarA mutant
strains.
Western blot analysis and zymography. The Bap immunoblotting assay was
performed as described previously (16). Briefly, S. aureus cells from a stationaryphase culture were resuspended to an optical density at 600 nm (OD600) of 40 in
100 mM PBS containing 5 mM EDTA and 1 mM phenylmethylsulfonyl fluoride.
Cells were centrifuged and suspended in 1 ml of digestion buffer (50 mM
Tris-HCl, pH 7.5, 20 mM MgCl2, and 30% raffinose [Sigma]). To each 1-ml
sample, 60 l protease inhibitors (Complete cocktail, Boehringer Mannheim), 40
l 50 mM phenylmethylsulfonyl fluoride, and 60 l of a 2-mg/ml solution of
lysostaphin (Sigma) were then added, and the suspension was incubated in a
37°C water bath for 30 min. Protoplasts were sedimented by centrifugation at
6,000 ⫻ g and the supernatant fraction, which contained the wall-associated
protein, was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (10% resolving gel, 4.5% stacking gel).
For Western blot analysis, protein extracts analyzed by SDS-PAGE as described above were blotted onto Immobilon P membrane (Millipore). Anti-Bap
serum (15) was diluted 1:2,500 with TTBS (Tris-buffer saline [50 mM Tris-HCl,
pH 7.5, 150 mM NaCl] containing 0.05% Tween 20) and immunoabsorbed with
1% skimmed milk. Alkaline phosphatase-conjugated protein A (Sigma) diluted
1:10,000 in TTBS-1% skimmed milk was used, and the subsequent chemiluminescence reaction (CSPD; Roche) was recorded.
Zymogram analysis was performed as previously described (35). Briefly, culture supernatants were subjected to SDS-PAGE using 12% acrylamide gels
containing gelatin (1 mg/ml; Difco). Following electrophoresis, the gels were
shaken gently for 60 min at room temperature in phosphate-buffered saline
(PBS) containing 2.5% (vol/vol) Triton X-100 (Sigma). The gels were then
incubated overnight at 37°C in buffer containing 50 mM Tris-HCl (pH 7.4), 200
mM NaCl, 5 mM CaCl2, 0.02% (vol/vol) Triton X-100, and 1 mM cysteine. The
gels were then stained with Coomassie blue dye and destained to reveal zones of
protease activity.
Isolation of RNA and Northern blot hybridization. Total RNA from S. aureus
was prepared by using a TRIzol isolation kit (Gibco BRL, Gaithersburg, Md.)
and a reciprocating shaker as described elsewhere (27). The optical density at
650 nm (OD650) of various cultures was determined with a spectrophotometer
(Spectronic 20). The concentration of RNA was determined by measuring the
absorbance at 260 nm, and 10 g of total RNA was analyzed by Northern
blotting as described previously (27). As probe, a fragment of the bap gene was
amplified by PCR using oligonucleotides sasp-6m (5⬘-CCCTATATCGAAGGT
GTAGAATTGCAC-3⬘) and sasp-7c (5⬘-GCTGTTGAAGTTAATACTGTACC
TGC-3⬘). An internal fragment of the 16S rRNA gene (nucleotides 777 to 1500;
GenBank accession no. X68417; oligonucleotides 16S rRNA-r, 5⬘-CCCCAATC
ATTTGTCCCACC-3⬘, and 16S rRNA-f, 5⬘-GCGTGGGGATCAAACAGG-3⬘)
was used as a loading control. For detection of specific transcripts, gel-purified
DNA probes were radiolabeled with [␣-32P]dCTP using the random-primed
DNA labeling kit (Roche Diagnostics GmbH) and hybridized under aqueous-
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phase conditions at 65°C. The blots were subsequently washed and autoradiographed.
Transcriptional fusion of the bap promoter to the luxABCDE reporter genes.
The promoter region and the ribosome-binding site from the bap gene was PCR
amplified using oligonucleotides pbap3mE (5⬘-CGGAATTCCGAGGTAGTTA
CAGATCAGGCACCT-3⬘) and pbap-2cA (5⬘-CCCCCGGGGGAAAATAATT
TTTTTTACAATTTTATGACGC) and cloned in the EcoRI-AvaI sites of plasmid pALC2485, a derivative of pSK236 containing luxABCDE at the SalI/PstI
site, generating pJP21. Plasmid pJP21 contains the transcriptional fusion of the
bap promoter to the luxABCDE reporter genes. Restriction analysis and DNA
sequencing confirmed the orientation and authenticity of the constructs. The
recombinant plasmid was first electroporated into S. aureus strain RN4220.
Plasmid from RN4220 was then transferred by phage transduction into JP61 and
JP65, the parental strain SH1000, and its sarA mutant containing the bap gene,
respectively, generating JP78 and JP79. Bioluminescence in these strains was
detected in a luminometer (Lumimark; Bio-Rad). Briefly, overnight cultures
were diluted (1:100) and grown at 37°C. One-hundred microliters of the sample
in triplicate was then withdrawn from the culture and assayed in microtiter plates
(catalog no. 3632; Costar). The data were reported as bioluminescence unit/
optical density (OD650).
Purification of SarA protein. The cloning and purification of the His6-tagged
fusion SarA protein were described earlier (12). The purity of the purified
His6-tagged SarA fusion protein was confirmed by sodium dodecyl sulfate (SDS)
gels stained with Coomassie Brilliant Blue R-250. The purified His6-tagged SarA
protein was found to be more than 98% pure in an SDS–12% polyacrylamide gel.
The concentration of the purified proteins was determined by the Bradford
protein assay (Bio-Rad, Hercules, Calif.), using bovine serum albumin as the
standard.
Gel shift analysis and DNase I footprinting. To determine if the SarA protein
binds to the bap promoter region, a 228-bp PCR-amplified fragment (oligonucleotides Bap-1mB and pbap-2cA), representing the bap promoter region, was
end labeled with [␥-32P]ATP by using T4 polynucleotide kinase. Labeled DNA
fragment (0.1 ng or 0.5 fmol) was incubated at room temperature (RT) for 20
min with various amounts of purified SarA protein in 25 l of binding buffer (25
mM Tris-Cl [pH 7.5], 0.1 mM EDTA, 75 mM NaCl, 1 mM dithiothreitol, and
10% glycerol) containing 0.5 g of calf thymus DNA (Amersham Pharmacia
Biotech). The reaction mixtures were analyzed in an 8.0% nondenaturing polyacrylamide gel. The band shifts were detected by exposing dried gels to X-ray
films.
Footprinting assays with template DNA fragment and DNase I were performed as previously described (3, 12). Upper and lower primers used for
amplifying the promoter region were 5⬘-ATACGGCAAAGAATACTTTAAAA
G-3⬘ and 5⬘-AAATAAATTTTTTTACAATTTTATGACGCA-3⬘, respectively.
To label PCR products, only one of the primers was labeled at one end. For the
assay, the binding reactions were carried out in a 100-l reaction volume containing 20 mM Tris-Cl (pH 8.0), 100 mM NaCl, 5 mM MgCl2, 1 mM CaCl2, 2
mM dithiothreitol, 10 g of bovine serum albumin, 0.4 g of calf thymus DNA,
radiolabeled template DNA (20,000 cpm), and various amounts of the purified
SarA protein at RT for 30 min. DNase I (0.02 U; Boehringer, Mannheim,
Germany) was added and allowed to incubate for 1 min at RT. The reaction
mixtures were extracted with phenol-chloroform, ethanol precipitated, washed
with 70% ethanol, dried, and resuspended in loading buffer (98% deionized
formamide, 10 mM EDTA [pH 8.0], 0.025% [wt/vol] xylene cyanol FF, 0.025%
[wt/vol] bromophenol blue). DNA samples were denatured at 95°C for 5 min and
analyzed on a 6% denaturing polyacrylamide sequence gel. The positions of the
protected region were derived by comparing the footprint with the A⫹G sequencing ladder of the same fragment.
5ⴕ-RACE (rapid amplification of cDNA 5ⴕ ends). Amplification of the bap
cDNA 5⬘ end was performed using the 5⬘/3⬘ RACE kit (Roche), according to the
manufacturer’s protocol. First-strand cDNA synthesis was performed using the
oligonucleotide bap52SP1-c (5⬘-TGGTAGATGCATCTTCATCTATTGC-3⬘)
according to the manufacturer’s instructions. The cDNA mixtures were amplified
by PCR using the oligo(dT) anchor primer and the gene-specific primer
bap53SP2-c (5⬘-CAGAAGATTGTGATGATGTATTCG-3⬘). The obtained
PCR products were analyzed in 1.2% agarose gels.
Statistical analysis. The data were analyzed by Student’s t test for unpaired
data to determine statistically significant differences. Differences were considered statistically significant when P was ⬍0.05 in all cases.

RESULTS
Construction and characterization of different derivatives of
laboratory strains carrying the bap gene. In a previous study,
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FIG. 1. A. Study of the presence of Bap by Western blotting. An
approximately 140-kDa band is recognized by polyclonal antibodies
against Bap only in bap-integrated strains JP60 and JP61. B. Biofilm
formation phenotype. Significant differences (P ⬍ 0.05) between the
wild-type strains Newman and SH1000 and the bap-integrated JP60
and JP61 strains in the capacity to form a 16-h biofilm on polystyrene
microtiter plates after staining with safranin was observed. C. Phenotypic differences between the wild-type strain Newman and the bapcomplemented strain JP60 in Congo red agar colony morphology.

we showed that a mutation in the sarA gene abolished biofilm
formation in V329, the prototypical bap-positive strain (41).
Considering that biofilm formation in this strain is Bap dependent (17), our result implies that expression of the Bap protein
could be regulated by SarA. To confirm that sarA regulates bap
gene expression, we first constructed JP60 and JP61, two recombinant derivative strains of Newman and SH1000, respectively, in which the bap gene had been integrated into the
bacterial chromosome. We constructed these strains in these
backgrounds because of their ease of genetic manipulation. In
addition, both of these strains contain functional global regulators, in contrast to some clinical isolates, in which some
regulators are muted. We observed that expression of the Bap
protein in JP60 and JP61 strains (Fig. 1A) rendered the bacteria competent for biofilm formation on microtiter wells (Fig.
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FIG. 2. A. Analysis of biofilm formation by S. aureus JP61 and
V329, their respective sarA mutants JP65 and JP62, and their respective sarA mutants complemented with plasmid pCU1-sar (strains JP69
and JP66). Significant differences in adherence (P ⬍ 0.05) were found
between wild-type strains and their respective sarA mutants, as well as
the sarA mutants versus sarA mutants complemented with pCU1-sarA.
B. Phenotypic differences between Bap-expressing strains JP61 and
V329 and their sarA mutants in Congo red agar colony morphology.

1B). In contrast to the parental strains, Bap-expressing strains
were positive for Congo red staining (Fig. 1C).
Effect of sarA on production of Bap and biofilm formation.
Null sarA mutants of S. aureus strains V329 and c104 (wildtype strains) and JP60 and JP61 (recombinant strains) were
analyzed for their ability to form biofilm on microtiter wells in
polystyrene plates. The sarA mutant strains JP62 (derivative of
V329) and JP65 (derivative of JP61) were deficient in biofilm
formation (Fig. 2A) and formed smooth colonies on Congo red
agar plates (Fig. 2B). Similar results were obtained when
strains JP63 (c104 sarA mutant) and JP64 (JP60 sarA mutant)
were analyzed (data not shown).
To confirm that the biofilm-deficient phenotypes were due
to sarA mutations, plasmid pCU1-sarA (carrying a PCR-amplified fragment containing the sarA gene under the control of
its promoter) was introduced into the sarA mutants JP62, JP63,
JP64, and JP65, generating strains JP66 to JP69, respectively.
The vector control was also introduced into the above sarA
mutant strains, generating strains JP70 to JP73. As shown in
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FIG. 3. Western blot analysis of Bap protein in S. aureus strains
JP61 and V329, their respective sarA mutants JP65 and JP62, and the
sarA mutants complemented with plasmid pCU1-sarA (JP69 and
JP66). Bap protein production was detected with an anti-Bap antiserum.

Fig. 2A, the complemented strains JP69 and JP66 displayed a
biofilm phenotype similar to that of the wild-type strains. Similar results were obtained when we analyzed the complemented
strains JP67 and JP68 (data not shown).
Effect of sarA on the expression of biofilm-associated protein. The expression of Bap in V329 and JP61 and their respective sarA mutant strains was also analyzed by Western
blotting. Consistent with the results of biofilm formation, the
cell wall extracts of the sarA mutants displayed undetectable
Bap levels compared to the respective isogenic parents (Fig. 3).
The expression of the Bap protein was restored in the complemented strains JP69 and JP66 (Fig. 3). As previously described, the size of the Bap protein varies between strains due
to the number of the C-repeats present in the protein (17).
The relationship between the extracellular proteolytic activity and the biofilm formation capacity of the sarA mutant
strains. Several extracellular proteases are overexpressed in
the sarA mutants (8). To determine if proteolytic cleavage of
the cell-wall-associated Bap protein resulted in loss of biofilmforming capacity in sarA mutants, we first constructed different
sarA mutants harboring a deletion of the aureolysin gene (aur)
or the serine protease gene (ssp) and then determined the
ability of the double mutants to produce a biofilm. The JP74
(derivative of JP64; aur mutant), JP75 (derivative of JP64; ssp
mutant), JP76 (derivative of JP65; aur mutant), and JP77 (derivative of JP65; ssp mutant) strains displayed a reduced capacity to form biofilm, similar to that of their isogenic sarA
mutant strains (Fig. 4A), while their capacities to produce
proteases were diminished, as verified by zymographic analysis
(Fig. 4B) and by growing the mutants in casein agar plates (Fig.
4C).
In addition, we performed biofilm formation assays on microtiter plates with the wild type and sarA mutants grown in the
presence of ␣2-macroglobulin, a universal protease inhibitor
that inhibits the activity of all major staphylococcal proteases
(41), and E64, a cysteine protease inhibitor, that inhibits two of
the major S. aureus proteases (SspB and Scp). No significant
differences were found in the biofilm-forming capacity of sarA
mutant cells grown in the presence or absence of ␣2-macroglobulin or E64 (data not shown). These data suggest that
extracellular proteases were likely not responsible for the biofilm deficiency of sarA mutant cells.
Transcriptional analysis of bap gene expression in sarAdeficient strains. To determine whether the effect of sarA

FIG. 4. (A) Comparison of the ability to produce a biofilm on
polystyrene microtiter dishes of S. aureus bap-integrated strains (JP60
and JP61), their corresponding sarA mutants (JP64, JP65), and the
sarA-aur and sarA-ssp mutant strains (JP74 and JP75 as well as JP76
and JP77, respectively). (B) Zymogram detection of secreted protease
activity after electrophoresis in 12% acrylamide gels containing gelatin
as substrate. Protease activity appears as a clear zone against a Coomassie blue-stained background. (C) Protease production by S. aureus
strains in casein agar plates.

occurs at the transcriptional level, expression of the bap gene
during the growth cycle of JP78 (JP61 carrying pJP21, the bap
promoter luxABCDE reporter construct) and its sarA mutant
JP79 (JP65 carrying pJP21) was monitored with a transcriptional fusion in which the bap promoter drives expression of
luxABCDE. For strain JP78, maximum bap expression was
observed during the exponential phase of growth (Fig. 5A).
The sarA mutant strain JP79 showed minimal transcription of
the bap gene during the entire growth cycle (Fig. 5A).
To confirm that sarA controls bap expression at the transcriptional level, we performed Northern blot analysis. Samples from JP60, JP61, JP64, and JP65 cultures were processed
for total RNA preparation at different time points. The RNAs
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FIG. 5. (A) Transcription of bap detected with a bap::luxABCDE
reporter fusion. Transcription of bap was monitored throughout the
growth cycle of strain JP78 (JP61 carrying pJP21) and its sarA mutant
JP79 (JP65 carrying pJP21). (B) Comparative measurement by Northern analysis of bap and 16S rRNA (control) transcription in wild-type
bap-integrated JP60 and sarA mutant JP64 S. aureus strains. RNA was
prepared from cultures grown in TSB at 37°C to early (OD650 ⫽ 0.6)
or late exponential phase (OD650 ⫽ 1) of the growth curve. Expression
of 16S rRNA is constitutive and was used as an internal control of this
experiment.

were probed with a bap gene probe and with a 16S rRNA
probe to monitor sample loading. An example of the Northern
blot is shown in Fig. 5B. Similar results were obtained with
samples from JP61 and JP65 (data not shown). As previously
described, the expression of the bap gene was reduced in the
sarA mutant strain.
SarA controls Bap expression by an agr-independent mechanism. Considering that SarA is a positive regulator of the agr
operon, and that agr regulates various virulence phenotypes
including biofilm formation (38), it is conceivable that SarA
could affect biofilm formation indirectly via agr. However, we
had demonstrated previously that strain JP80 (agr mutant derivative of V329) was not affected in its capacity to form a
biofilm (40), suggesting that SarA affected bap expression via
an agr-independent pathway. To test this hypothesis, we created insertional agr mutations in JP60 and JP61 strains, gen-
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erating strains JP81 and JP82, respectively. Neither Bap expression nor biofilm formation capacity in microtiter wells was
affected in the agr mutant strains (data not shown).
Transcriptional start sites and promoter structure of the
bap gene. To determine the transcriptional start site and the
promoter sequence, 5⬘-RACE analysis was performed with
total RNA isolated from the wild-type strains V329 and JP61.
The transcriptional start site was mapped to a G, which was
located 106 bp upstream of the initiation codon ATG (Fig.
6C). Based upon the transcriptional start site, the predicted
putative promoter boxes are TTTACT(⫺35)-N16-TATAAT
(⫺10), which has close homology with the ⫺10 and ⫺35 consensus sequences of A-dependent promoters (Fig. 6B). A
ribosome binding site, GAGGTG, was located 7 bp upstream
of the ATG translational start codon.
SarA binds to the bap promoter. Because sarA controls bap
expression by an agr-independent mechanism we tested
whether SarA binds specifically to the bap promoter. Histidinetagged SarA was expressed in Escherichia coli and purified to
homogeneity. Purified recombinant SarA was allowed to bind
to an end-labeled 228-bp PCR fragment representing the entire bap promoter in electrophoretic mobility shifts assays. As
shown in Fig. 7, the recombinant SarA protein induced shifts in
the bap promoter probe. The binding appeared to be specific
because SarA-induced shifts were not affected when a 10-fold
excess of nonspecific unlabeled DNA fragment was used as a
competitor (Fig. 7). Hence, SarA protein can bind to the bap
promoter region, presumably acting as an activator to bap
transcription. To verify the DNA binding specificity and to
map the binding sites, we performed DNase I protection assays
with a 295-bp bap promoter fragment labeled with ␥-32P at one
end in the presence of SarA. As shown in Fig. 6, protection
from DNase I digestion with SarA was mapped to three regions very close to each other. The putative protected regions
of SarA are from positions ⫺169 to ⫺146 bp (Fig. 6, top strand
of DNA) and ⫺55 to ⫺30 and ⫺19 to ⫹61 bp of the transcriptional start site (Fig. 6, bottom strand of DNA). A close analysis of this sequence revealed that the protected regions closely
resemble the SarA consensus DNA binding motif (ATTTGT
ATTTAATATTTATATAATTG) previously reported (12).
Boxes I, II, and III have 15 of 25, 17 of 25, and 15 of 25 matches
to the SarA consensus binding sequence, respectively, thus
verifying that the DNA binding site of SarA on the bap promoter is likely specific and further confirming previous studies
on the predicted SarA binding consensus sequence.
DISCUSSION
Although PNAG, the product of the intercellular adhesion
locus (icaADBC), has been shown to be critical for biofilm
formation in S. aureus, it has been recently reported that ica is
not absolutely required for biofilm formation in at least some
strains of S. aureus. This finding corroborated our recent data,
showing that bap-positive strains are capable of biofilm formation in the absence of the ica operon (17). In addition, Beenken et al. demonstrated that mutation of ica in strain UAMS-1
had little impact on biofilm formation (5). In this study, we
evaluated the regulation of the factor Bap by the global regulators agr and sarA. Examination of bap mRNA production by
different strains at various growth phases showed that sarA was
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FIG. 6. DNase I footprinting analysis of SarA binding to the bap promoter region. (A) Footprint analysis of SarA binding to the top strand of
the bap promoter region. A 295-bp bap promoter fragment was end labeled (top strand) with [␥-32P]ATP. The protein lanes (lanes 2 to 5) (0.25,
0.5, 1, and 2 g of SarA) as well as no-protein controls (lanes 1 and 6) are shown. The A to G ladder is also labeled (M). (B) Footprinting analysis
of the bottom strand of the bap promoter region. The lanes contain 0.5, 1, and 2 g of SarA (lanes 3 to 5) or no-protein control (lanes 1 and 6).
(C) Nucleotide sequence of the bap gene is shown and marked with the putative promoter region and start site as derived from the 5⬘-RACE data.
The putative protected regions for SarA on the promoter are marked.

the main positive regulator of Bap expression. Interestingly, we
and other have identified SarA as essential for the ica-dependent biofilm formation process, both in S. aureus (4, 41) and in
S. epidermidis (39). Interestingly, Beenken et al. also disclosed
that the unidentified factor responsible for the biofilm-positive
phenotype of strain UAMS-1 was regulated by SarA (5). Taken
together, these results strongly suggest that SarA is an essential
regulator controlling biofilm formation in S. aureus by several
mechanisms.

Several recent studies have shown discrepancies in the regulatory roles of sarA and B. While we and others described
sarA and not B as a positive regulator of biofilm formation (4,
41), Pratten et al. established that sarA mutation increased
adherence to glass (33). Contrary to our data (41), Rachid et
al. suggested that B was required for biofilm formation (34).
It is conceivable that use of genetically unrelated strains may
account for these discrepancies, since some studies have recently demonstrated the existence of strain-dependent differ-
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FIG. 7. Binding of SarA to bap promoter. Mobility of the DNA
band in the presence of increasing amounts of SarA protein is indicated on the top. In competition assays, 10-fold excesses of nonspecific
unlabeled DNA fragments were added with 500 ng of SarA.

ences in the regulatory roles of sarA and agr in S. aureus (6).
Another plausible explanation may be that spontaneous mutations in global regulator genes may occur in some isolates of
S. aureus as has been found in S. epidermidis (42, 43, and our
unpublished results). For these reasons, to determine whether
the phenotypes of strains V329 and c104 and the impact of
sarA are representative and independent of the strain used, we
expressed Bap in different genetic backgrounds, including
strains Newman and SH1000. In strains Newman and SH1000,
global regulators, including agr, sar, and B, are fully functional. Interestingly, in all cases, a sarA mutation resulted in
reduced capacity to express Bap and form biofilm. This finding
confirmed the important role of SarA in controlling Bap expression.
Extracellular proteases expressed by S. aureus have been
shown to degrade proteins on the surface of the bacteria (23,
28). Because protease production is upregulated in sarA mutants (8), we assessed if the decreased expression of Bap on the
surface of the bacteria might be attributable to proteolytic
cleavage of the protein. As the sar-aur and sar-ssp double
mutants had defects in biofilm formation similar to the single
sar mutant, we conclude that SarA-regulated proteases have
little effect on biofilm formation in sarA mutants. Additionally,
differential expression of cell-wall-associated Bap was mainly
detectable during the exponential phase, a part of the growth
cycle in which the secretion of proteases is not dominant (unpublished observation). However, because there are multiple
proteases in S. aureus, we cannot rule out the possibility that
enhanced proteolytic activity in the sarA mutant may contribute to the overall decrease in Bap-mediated biofilm formation.
Several studies have demonstrated that SarA modulates the
expression of a number of S. aureus virulence factors, including
clfB, agr, fnbA, fnbB, spa, hla, and sspA (10). In many cases, this
regulation occurs via a direct interaction between SarA and
promoter elements of the target genes. In gel shift studies we
found that purified SarA protein formed complexes with the
bap promoter with fairly high affinity. The specificity of the
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SarA protein was determined by DNase I footprinting. Three
SarA binding regions (boxes I, II, and III) were found within
the 295-bp bap promoter sequence. Interestingly, each of these
three binding regions resembles the SarA consensus binding
motif or the SarA box (12). These findings are consistent with
the notion that SarA may activate bap via direct binding into
the bap promoter region.
In a previous study, we demonstrated that expression of the
Bap protein blocked the activity of two MSCRAMM proteins
of the S. aureus and reduced colonization capacity of Bapexpressing strains (16). In that study, the blocking capacity of
the Bap protein was observed using stationary-phase cells.
However, here we showed that Bap is expressed during the
exponential phase of growth, as are the fibronectin-binding
proteins (37), the collagen-binding protein (20), and the
clumping factor B (29). Bap expressed during this phase of
growth will block MSCRAMM activity, suggesting additional
roles for this protein in staphylococcal pathogenesis to compensate the activity of the blocked proteins. Interestingly, an
extracellular module, HYR, involved in cellular adhesion is
present in the C repeats of Bap (20).
Bacteria seem to initiate biofilm development in response to
a variety of environmental signals, such as nutrient and oxygen
availability, osmolarity, temperature, or pH. Interestingly, in
addition to the genetic control here reported, we found that
addition of millimolar amounts of calcium to the growth media
inhibited intercellular adhesion and biofilm formation by Bappositive strain V329 (1). Our results also demonstrated that the
Ca2⫹ inhibition of the Bap-mediated bacterial multicellular
behavior was not due to repression of Bap expression. Instead,
our results were consistent with the hypothesis that calcium
causes a conformational change in Bap that affects its ability to
form biofilms (1). The fact that calcium inhibition of Bapdependent biofilm formation takes place in vitro at concentrations similar to those found in milk serum supports the possibility that this inhibition could be important to the
pathogenesis of the bacteria.
To the recently characterized roles of the SarA protein in
the regulation of biofilm formation (4, 5, 41), we have now
added a role for sarA in the upregulation of Bap expression
and biofilm development. The regulation of these processes by
SarA suggests that SarA may be a promising target to control
biofilm development and the infective process of S. aureus.
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44. Wolz, C., P. Pöhlmann-Dietze, A. Steinhuber, T. T. Chien, A. Manna, W. van
Wamel, and A. Cheung. 2000. Agr-independent regulation of fibronectinbinding protein(s) by the regulatory locus sar in Staphylococcus aureus. Mol.
Microbiol. 36:230–243.

